Council of the European Union Brussels, 4 April 2017 (OR. en)

Transcription

1 Council of the European Union Brussels, 4 April 2017 (OR. en) 7868/17 ADD 1 COVER NOTE From: European Commission date of receipt: 28 March 2017 To: General Secretariat of the Council No. Cion doc.: D049962/02 ANNEX 1 Subject: COMPET 232 V 319 CHIMIE 38 MI 309 T 91 SAN 133 CONSOM 124 ANNEX to the COMMISSION REGULATION (EU) / of xxx amending the Appendices to Annex XVII to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) as regards CMR substances Delegations will find attached document D049962/02 ANNEX 1. Encl.: D049962/02 ANNEX /17 ADD 1 TG/add DG G 3 A

2 EUROPEAN COMMISSION Brussels, XXX D049962/02 [ ](2017) XXX draft ANNEX 1 ANNEX to the COMMISSION REGULATION (EU) / of xxx amending the Appendices to Annex XVII to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) as regards CMR substances

3 ANNEX Annex XVII to Regulation (EC) No 1907/2006 is amended as follows: (1) In Appendix 2, the following entries are inserted in the table in order of the index numbers set out therein: '1,2-dichloropropane; propylene dichloride e-glass microfibres of representative composition; [Calcium-aluminium-silicate fibres with random orientation with the following representative composition (% given by weight): SiO %, Al 2 O %, B 2 O %, Na 2 O <0.6 %, K 2 O <0.4 %, CaO %, MgO <5.5 %, Fe 2 O 3 <0.5 %, F 2 <1.0 %. Process: typically produced by flame attenuation and rotary process. (Additional individual elements may be present at low levels; the process list does not preclude innovation).] ' (2) In Appendix 4, the following entry is inserted in the table in order of the index number set out therein: '3,7-dimethylocta-2,6-dienenitrile ' (3) In Appendix 5, (a) the following entries are inserted in the table in order of the index numbers set out therein: 'brodifacoum (ISO); 4-hydroxy-3-(3-(4'-bromo-4-biphenylyl)-1,2,3,4- tetrahydro-1-naphthyl)coumarin lead powder; [particle diameter < 1 mm] lead massive: [particle diameter 1 mm] ' (b) the entry relating to warfarin; 4-hydroxy-3-(3-oxo-1- phenylbutyl)-coumarin is replaced by the following entry: 'warfarin (ISO); 4-hydroxy-3-(3-oxo-1- phenylbutyl)-2hchromen-2-one; [1] (S)-4-hydroxy-3-(3-oxo- 1-phenylbutyl)-2- benzopyrone; [2] (R)-4-hydroxy-3-(3-oxo- 1-phenylbutyl)-2- benzopyrone [3] [1] [2] [3] [1] [2] [3]' 1

4 (4) In Appendix 6, (a) the following entries are inserted in the table in order of the index numbers set out therein: 'tetrahydro-2-furyl-methanol; tetrahydrofurfuryl alcohol gallium arsenide Tributyltin compounds, with the exception of those specified elsewhere in this Annex 1,2-benzenedicarboxylic acid, dihexyl ester, branched and linear imidazole bisphenol A; 4,4'-isopropylidenediphenol phenol, dodecyl-, branched; [1] phenol, 2-dodecyl-, branched; [2] phenol, 3-dodecyl-, branched; [3] phenol, 4-dodecyl-, branched; [4] phenol, (tetrapropenyl) derivatives [5] [1] - [4] [1] [4] - [5] [5] chlorophacinone (ISO);2-[(4- chlorophenyl)(phenyl)acetyl]-1h-indene- 1,3(2H)-dione coumatetralyl (ISO); 4-hydroxy-3-(1,2,3,4- tetrahydro-1-naphthyl)coumarin difenacoum (ISO); 3-(3-biphenyl-4-yl-1,2,3,4- tetrahydro-1-naphthyl)-4-hydroxycoumarin flocoumafen (ISO); reaction mass of: cis-4- hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4- trifluoromethylbenzyloxy)phenyl)-1- naphthyl)coumarin and trans-4-hydroxy-3- (1,2,3,4-tetrahydro-3-(4-(4- trifluoromethylbenzyloxy)phenyl)-1- naphthyl)coumarin X disodium octaborate anhydrous; [1] disodium octaborate tetrahydrate [2] [1] [2] [1] [2] difethialone (ISO); bromadiolone (ISO); 3-[3-(4'-bromobiphenyl-4- yl)-3-hydroxy-1-phenylpropyl]-4-hydroxy-2hchromen-2-one 3-[3-(4'-bromobiphenyl-4-yl)-1,2,3,4- tetrahydronaphthalen-1-yl]-4-hydroxy-2h-1- benzothiopyran-2-one perfluorononan-1-oic acid [1] and its sodium [2] and ammonium [3] salts dicyclohexyl phthalate [1] [1] [2] [3]

5 triflumizole (ISO); (1E)-N-[4-chloro-2-(trifluoromethyl)phenyl]-1- (1H-imidazol-1-yl)-2-propoxyethanimine ' (b) the entry relating to flumioxazin (ISO); N-(7-fluoro-3,4-dihydro-3-oxo-4-prop-2-ynyl) 2,H 1,4-benzoxazin-6-yl) cyclohex-1-ene-1,2dicarboxamide is replaced by the following entry: 'flumioxazin (ISO); 2-[7-fluoro-3-oxo-4- (prop-2- yn-1-yl)-3,4-dihydro-2h-1,4-benzoxazin-6-yl]- 4,5,6,7-tetrahydro-1H-isoindole-1,3 (2H)-dione X ' 3